Separase is a marker for prognosis and mitotic activity in breast cancer.

about

Separase Inhibitor Sepin-1 Inhibits Foxm1 Expression and Breast Cancer Cell Growth.Integrated Analysis Reveals That miR-193b, miR-671, and TREM-1 Correlate With a Good Response to Treatment of Human Localized Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

P2860

Q54108531-D7521E3B-4DF9-424A-ACC3-EDFCB0574DA6 Q55312793-6DC22006-6CB5-443D-98E8-A041205D3EC0

P2860

Separase is a marker for prognosis and mitotic activity in breast cancer.

Item

http://www.wikidata.org/entity/Q38599786

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Separase is a marker for prognosis and mitotic activity in breast cancer.

@en

type

Item

label

Separase is a marker for prognosis and mitotic activity in breast cancer.

@en

prefLabel

Separase is a marker for prognosis and mitotic activity in breast cancer.

@en

P1476

Separase is a marker for prognosis and mitotic activity in breast cancer

@en

P2093

Eliisa Löyttyniemi

http://www.w3.org/2001/XMLSchema#string

Kati Talvinen

http://www.w3.org/2001/XMLSchema#string

Marjukka Nykänen

http://www.w3.org/2001/XMLSchema#string

Natalia Gurvits

http://www.w3.org/2001/XMLSchema#string

Pauliina Kronqvist

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of human separase by securin binding and autocleavage

Separase is recruited to mitotic chromosomes to dissolve sister chromatid cohesion in a DNA-dependent manner

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

Biomarkers in triple negative breast cancer: A review

Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast.

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Identifying common prognostic factors in genomic cancer studies: a novel index for censored outcomes.

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

P2888

bjc.2017.301

P304

1383-1391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2017.301

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

T Kuopio

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091394298

http://www.w3.org/2001/XMLSchema#string

P698

28859055

http://www.w3.org/2001/XMLSchema#string

P932

5672940

http://www.w3.org/2001/XMLSchema#string

Separase is a marker for prognosis and mitotic activity in breast cancer.

about

P2860

P2860

Separase is a marker for prognosis and mitotic activity in breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932